Regulation of energy and glucose homeostasis by endogenous hypothalamic FGF1
内源性下丘脑 FGF1 对能量和葡萄糖稳态的调节
基本信息
- 批准号:10191788
- 负责人:
- 金额:$ 13.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAffectAnimalsAntibodiesAntidiabetic DrugsAreaAwardBilateralBiochemicalBody WeightBody Weight decreasedBrainCaloriesCell LineCell NucleusCellsCerebrospinal FluidChronicChronic DiseaseConsumptionDataDependovirusDesire for foodDiabetes MellitusDietDisease remissionEnterobacteria phage P1 Cre recombinaseExpenditureFGF1 geneFGF19 geneFGF21 geneFamilyFastingFibroblast Growth FactorFoodFundingGliosisGlucoseGlucose IntoleranceHomeostasisHypothalamic structureImmunohistochemistryIn Situ HybridizationInfusion proceduresInjectionsInvestigationKnock-outLipidsLoxP-flanked alleleMedicalMessenger RNAMetabolicMicroinjectionsModelingModernizationMorbidity - disease rateMusNeurogliaNeuronal InjuryNeuronsNon-Insulin-Dependent Diabetes MellitusNutritional statusObesityPatient-Focused OutcomesPeripheralPhysiologicalPlayPopulationPrimatesProteinsPublic HealthRegulationReportingResearchResourcesRodentRodent ModelRoleSignal TransductionSocietiesSurveysSynapsesTestingTreatment outcomeWeight GainWorkbaseblood glucose regulationcell typecostdiabeticeffective therapyenergy balanceglucose tolerancehuman modelimprovedinterestlaser capture microdissectionmembermetabolic phenotypemind controlmortalitynovelobesity developmentobesity treatmentpre-clinicalresponsesedentary lifestylestemtargeted treatmentwestern diet
项目摘要
Project Summary
Over the past 3 decades, obesity and type 2 diabetes (T2D) have emerged as among the most common and
costly chronic diseases confronting modern society. Treatment outcomes for patients affected with obesity or
T2D have shown minimal improvement due to the absence of non-surgical medical treatments that have
sustained efficacy. Therefore, an urgent need for new, more effective treatment options therefore exists, and
strategies targeting the brain have important potential to meet this need. As one example of relevant preclinical
work, our group has recently shown that signaling in the brain by exogenous administration of members of the
fibroblast growth factor (FGF) family produces potent weight-loss and anti-diabetic effects. Our K08 proposal
focused on the integrated central and peripheral mechanisms underlying the sustained anti-diabetic action of
exogenous FGF1 in rodent models of obesity and T2D. In this application, we propose a parallel line of studies
that will investigate the role of endogenous hypothalamic FGF1 signaling in the regulation of energy and glucose
homeostasis. We have recently found that FGF1 is endogenously expressed by tanycytes and cells distributed
in a number of key hypothalamic areas implicated in the control of body weight and glucose. Further, we have
observed that endogenous hypothalamic FGF1 expression is regulated fasting and refeeding and in preliminary
studies that deleting FGF1 from either hypothalamic neurons or tanycytes induces weight gain and glucose
intolerance on chow diet. These data support the premise that endogenous hypothalamic FGF1 signaling plays
a physiologic role in the regulation of energy and glucose homeostasis. We will investigate this hypothesis by
determining the specific hypothalamic nuclei and cell types that express FGF1, identify which of these
populations respond to acute and chronic changes in metabolic status and diet, and the extent to which disrupting
endogenous hypothalamic FGF1 signaling is sufficient to promote the development of obesity and glucose
intolerance. The data obtained from these investigations will form the basis of a new line of research centered
on endogenous hypothalamic FGF1 signaling as a novel target to treat obesity and T2D.
项目摘要
在过去的30年里,肥胖和2型糖尿病(T2D)已经成为最常见和最常见的糖尿病之一。
现代社会所面临的昂贵的慢性病。肥胖患者的治疗结局,或
由于缺乏非手术药物治疗,T2D显示出最小的改善,
持续的功效。因此,迫切需要新的、更有效的治疗选择,
针对大脑的战略具有满足这一需求的重要潜力。作为相关临床前
工作,我们的小组最近表明,信号在大脑中的外源性管理的成员,
成纤维细胞生长因子(FGF)家族产生有效的减肥和抗糖尿病作用。我们的K08提案
集中在持续的抗糖尿病作用的基础上的综合中枢和外周机制
在肥胖和T2D啮齿动物模型中的外源性FGF 1。在这个应用中,我们提出了一个平行的研究路线,
研究内源性下丘脑FGF1信号在能量和葡萄糖调节中的作用
体内平衡我们最近发现,FGF 1是内源性表达的伸长细胞和细胞分布,
在许多关键的下丘脑区域,涉及体重和葡萄糖的控制。您因前述
观察到内源性下丘脑FGF1表达受禁食和再喂养的调节,
研究表明,从下丘脑神经元或伸长细胞中删除FGF1会导致体重增加和葡萄糖
对食物不耐受。这些数据支持了内源性下丘脑FGF 1信号传导发挥作用的前提,
在能量和葡萄糖稳态调节中的生理作用。我们将调查这一假设,
确定表达FGF 1的特定下丘脑核和细胞类型,
人群对代谢状态和饮食的急性和慢性变化的反应,以及干扰的程度。
内源性下丘脑FGF 1信号传导足以促进肥胖和葡萄糖代谢的发展。
不容忍从这些调查中获得的数据将形成一个新的研究路线的基础,
内源性下丘脑FGF1信号传导作为治疗肥胖和T2D的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrad M Scarlett其他文献
Jarrad M Scarlett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrad M Scarlett', 18)}}的其他基金
Regulation of energy and glucose homeostasis by endogenous hypothalamic FGF1
内源性下丘脑 FGF1 对能量和葡萄糖稳态的调节
- 批准号:
10368119 - 财政年份:2021
- 资助金额:
$ 13.24万 - 项目类别:
Central and Peripheral Mechanisms of FGF1-Mediated Remission of Diabetic Hyperglycemia
FGF1介导缓解糖尿病高血糖的中枢和外周机制
- 批准号:
9370073 - 财政年份:2017
- 资助金额:
$ 13.24万 - 项目类别:
Regulation of glucose homeostasis by intestinal macronutrients and surgery
肠道大量营养素和手术对葡萄糖稳态的调节
- 批准号:
8832013 - 财政年份:2014
- 资助金额:
$ 13.24万 - 项目类别:
Regulation of glucose homeostasis by intestinal macronutrients and surgery
肠道大量营养素和手术对葡萄糖稳态的调节
- 批准号:
9017811 - 财政年份:2014
- 资助金额:
$ 13.24万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 13.24万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 13.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)